CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-09 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,163 | $22.99 | $27K | 26,336 |
| 2024-01-09 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,789 | $22.99 | $41K | 27,869 |
| 2024-01-05 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +25,527 | 52,119 | ||
| 2024-01-05 | Goff Brian Chief Executive Officer | Option exercise · Performance share units 10b5-1 | −25,527 | 119,128 | ||
| 2024-01-05 | FOUSE JACQUALYN A Director | Option exercise 10b5-1 | +17,500 | 124,466 | ||
| 2024-01-05 | FOUSE JACQUALYN A Director | Option exercise · Performance share units 10b5-1 | −17,500 | 0 | ||
| 2024-01-05 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +3,250 | 27,499 | ||
| 2024-01-05 | Burns James William Chief Legal Officer | Option exercise · Performance share units 10b5-1 | −3,250 | 0 | ||
| 2024-01-05 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +5,000 | 29,658 | ||
| 2024-01-05 | Gheuens Sarah Chief Medical Officer | Option exercise · Performance share units 10b5-1 | −5,000 | 0 | ||
| 2024-01-05 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −2,902 | $22.32 | $65K | 9,404 |
| 2024-01-03 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +8,475 | 12,306 | ||
| 2024-01-03 | Milanova Tsveta Chief Commercial Officer | Option exercise · Restricted stock units 10b5-1 | −8,475 | 16,951 | ||
| 2023-09-28 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −2,179 | $24.79 | $54K | 9,575 |
| 2023-09-26 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +7,472 | 11,754 | ||
| 2023-09-26 | Jones Cecilia Chief Financial Officer | Option exercise · Restricted stock units 10b5-1 | −7,472 | 14,945 | ||
| 2023-08-17 | Burns James William Chief Legal Officer | Sale | −6,395 | $26.28 | $168K | 23,890 |
| 2023-08-11 | Ballal Rahul D. Director | Option exercise | +2,302 | 2,302 | ||
| 2023-08-11 | Ballal Rahul D. Director | Option exercise · Restricted stock units | −2,302 | 4,604 | ||
| 2023-08-11 | Smith Cynthia Director | Option exercise | +2,302 | 2,302 |
Page 26 of 48 · 941 trades